1. Home
  2. VIAV vs BMRN Comparison

VIAV vs BMRN Comparison

Compare VIAV & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$43.28

Market Cap

10.6B

Sector

Technology

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$67.45

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIAV
BMRN
Founded
1923
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
11.4B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
VIAV
BMRN
Price
$43.28
$67.45
Analyst Decision
Strong Buy
Buy
Analyst Count
8
18
Target Price
$32.66
$88.22
AVG Volume (30 Days)
5.2M
2.1M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.77
Revenue
$1,518,300,000.00
$1,313,646,000.00
Revenue This Year
$37.78
$15.02
Revenue Next Year
$10.64
$12.23
P/E Ratio
N/A
$88.99
Revenue Growth
40.03
17.62
52 Week Low
$10.45
$49.26
52 Week High
$60.43
$70.98

Technical Indicators

Market Signals
Indicator
VIAV
BMRN
Relative Strength Index (RSI) 54.48 66.40
Support Level $36.25 $58.03
Resistance Level $43.74 N/A
Average True Range (ATR) 2.77 2.13
MACD 0.92 0.74
Stochastic Oscillator 87.05 70.72

Price Performance

Historical Comparison
VIAV
BMRN

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: